glp 1 clinical trials Continued growth for GLP-1 receptor agonists and SGLT-2 inhibitors in 2017 2025 dominates for GLP-1 trial
Description
These drugs can help people with type 2 diabetes achieve an A1C (a marker of blood sugar control over time) goal of less than 7%
95%CI 0.380.98) (Sattar et al., 2021)
The hypoglycemic effects of banaba have been attributed to both corosolic acid as well as ellagitannins
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER As an observational study rather than a controlled clinical trial, it could not definitively prove that the genetic variants caused the difference in weight loss, only that they are associated with it, the researchers noted
Subscribe today to stay updated on the latest in health and nutrition, receive valuable health tips, and enjoy exclusive offers from Unjury
This article first appeared on KFF Health News and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License.
